{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:23:31Z","timestamp":1791869011382,"version":"4.3.4"},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":277,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH106037"],"award-info":[{"award-number":["MH106037"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1002\/da.22329","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:10:51Z","timestamp":1417219851000},"page":"149-157","source":"Crossref","is-referenced-by-count":165,"title":["EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN PEDIATRIC ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS"],"prefix":"10.1155","volume":"32","author":[{"given":"Jeffrey R.","family":"Strawn","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience; University of Cincinnati, College of Medicine; Cincinnati Ohio"},{"name":"Department of Psychiatry; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Welge","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience; University of Cincinnati, College of Medicine; Cincinnati Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Wehry","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience; University of Cincinnati, College of Medicine; Cincinnati Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks","family":"Keeshin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience; University of Cincinnati, College of Medicine; Cincinnati Ohio"},{"name":"Department of Pediatrics; University of Utah; Salt Lake City Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira A.","family":"Rynn","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute (NYSPI); Department of Psychiatry, Columbia University; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"issue":"4","key":"10.1002\/da.22329-BIB0001|da22329-cit-0001","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","article-title":"Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement","volume":"69","author":"Kessler","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1002\/da.22329-BIB0002|da22329-cit-0002","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","article-title":"Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A)","volume":"49","author":"Merikangas","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1002\/da.22329-BIB0003|da22329-cit-0003","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.63.9.1017","article-title":"Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study","volume":"63","author":"Foley","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1002\/da.22329-BIB0004|da22329-cit-0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/15374410801955771","article-title":"Psychiatric impairment among adolescents engaging in different types of deliberate self-harm","volume":"37","author":"Jacobson","year":"2008","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"1","key":"10.1002\/da.22329-BIB0005|da22329-cit-0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","article-title":"The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders","volume":"55","author":"Pine","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22329-BIB0006|da22329-cit-0006","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1002\/da.22329-BIB0007|da22329-cit-0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archgenpsychiatry.2009.177","article-title":"Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder","volume":"67","author":"Beesdo","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1002\/da.22329-BIB0008|da22329-cit-0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.chc.2012.05.002","article-title":"Neural substrates of childhood anxiety disorders: a review of neuroimaging findings","volume":"21","author":"Blackford","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"10.1002\/da.22329-BIB0009|da22329-cit-0009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/da.21913","article-title":"Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder","volume":"29","author":"Strawn","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.22329-BIB0010|da22329-cit-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-4-1","article-title":"Child\/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods","volume":"4","author":"Compton","year":"2010","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"3","key":"10.1002\/da.22329-BIB0011|da22329-cit-0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chc.2012.05.003","article-title":"Psychopharmacologic treatment of children and adolescents with anxiety disorders","volume":"21","author":"Strawn","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"3","key":"10.1002\/da.22329-BIB0012|da22329-cit-0012","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.janxdis.2010.01.009","article-title":"Clinical characteristics of anxiety disordered youth","volume":"24","author":"Kendall","year":"2010","journal-title":"J Anxiety Disord"},{"key":"10.1002\/da.22329-BIB0013|da22329-cit-0013","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1002\/da.22329-BIB0014|da22329-cit-0014","first-page":"CD005170","article-title":"Pharmacotherapy for anxiety disorders in children and adolescents","volume":"3","author":"Ipser","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1002\/da.22329-BIB0015|da22329-cit-0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","article-title":"The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties","volume":"41","author":"RUPP","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1002\/da.22329-BIB0016|da22329-cit-0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1002\/da.22329-BIB0017|da22329-cit-0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1207\/s15374424jccp2201_2","article-title":"The social anxiety scale for children-revised: factor structure and concurrent validity","volume":"22","author":"La Greca","year":"1993","journal-title":"J Clinical Child Psychol"},{"issue":"10","key":"10.1002\/da.22329-BIB0018|da22329-cit-0018","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biopsych.2007.02.025","article-title":"A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder","volume":"62","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22329-BIB0019|da22329-cit-0019","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","volume":"61","author":"Wagner","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22329-BIB0020|da22329-cit-0020","volume-title":"Methods for Meta-Analysis in Medical Research","author":"Sutton","year":"2000"},{"key":"10.1002\/da.22329-BIB0021|da22329-cit-0021","volume-title":"The Handbook of Research Synthesis","author":"Cooper","year":"1994"},{"key":"10.1002\/da.22329-BIB0022|da22329-cit-0022","first-page":"397","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"O'Donnell","year":"2011"},{"issue":"6","key":"10.1002\/da.22329-BIB0023|da22329-cit-0023","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/00004583-199407000-00016","article-title":"Response of children with ADHD to methylphenidate: interaction with internalizing symptoms","volume":"33","author":"DuPaul","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1002\/da.22329-BIB0024|da22329-cit-0024","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00004583-198911000-00012","article-title":"Effect of anxiety on cognition, behavior, and stimulant response in ADHD","volume":"28","author":"Pliszka","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1002\/da.22329-BIB0025|da22329-cit-0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1002\/da.22329-BIB0026|da22329-cit-0026","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","author":"RUPP","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/da.22329-BIB0027|da22329-cit-0027","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/ajp.2007.164.2.290","article-title":"Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials","volume":"164","author":"Rynn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22329-BIB0028|da22329-cit-0028","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder","volume":"158","author":"Rynn","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22329-BIB0029|da22329-cit-0029","volume-title":"Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"Strawn","year":"2013"},{"issue":"4","key":"10.1002\/da.22329-BIB0030|da22329-cit-0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1002\/da.22329-BIB0031|da22329-cit-0031","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/chi.0b013e318154bb57","article-title":"SET-C versus fluoxetine in the treatment of childhood social phobia","volume":"46","author":"Beidel","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1002\/da.22329-BIB0032|da22329-cit-0032","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22329-BIB0033|da22329-cit-0033","unstructured":"US Food and Drug Administration Relationship between psychotropic drugs and pediatric suicidality: review and evaluation of clinical data. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4065b1-10-TAB08-Hammads-Review.pdf"},{"issue":"4","key":"10.1002\/da.22329-BIB0034|da22329-cit-0034","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10578-013-0410-x","article-title":"Somatic complaints in anxious youth","volume":"45","author":"Crawley","year":"2014","journal-title":"Child Psychiatry Hum Dev"},{"key":"10.1002\/da.22329-BIB0035|da22329-cit-0035","first-page":"339","article-title":"Fluoxetine-induced akathisia: clinical and theoretical implications","volume":"50","author":"Lipinski","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22329-BIB0036|da22329-cit-0036","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cap.1990.1.193","article-title":"Behavioral side effects of fluoxetine in children and adolescents","volume":"1","author":"Riddle","year":"1991","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1002\/da.22329-BIB0037|da22329-cit-0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/104454601750143320","article-title":"Complications of SSRI treatment","volume":"11","author":"Walkup","year":"2001","journal-title":"J child Adolesc Psychopharmacol"},{"key":"10.1002\/da.22329-BIB0038|da22329-cit-0038","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents","volume":"16","author":"Safer","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1002\/da.22329-BIB0039|da22329-cit-0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/cap.2008.040","article-title":"Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents","volume":"19","author":"Reinblatt","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1002\/da.22329-BIB0040|da22329-cit-0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/104454603322163862","article-title":"A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors","volume":"13","author":"Wilens","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1002\/da.22329-BIB0041|da22329-cit-0041","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/cap.2006.16.147","article-title":"Antidepressant side effects in children and adolescents","volume":"16","author":"Gualtieri","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1002\/da.22329-BIB0042|da22329-cit-0042","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1002\/da.22329-BIB0043|da22329-cit-0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004850-199503000-00007","article-title":"SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients","volume":"10","author":"Filteau","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"issue":"1-2","key":"10.1002\/da.22329-BIB0044|da22329-cit-0044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-003-1698-1","article-title":"Prediction of the response to ditalopram and reboxetine in post-stroke depressed patients","volume":"173","author":"Rampello","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1002\/da.22329-BIB0045|da22329-cit-0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4088\/JCP.v69n0812","article-title":"Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies","volume":"69","author":"Papakostas","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1002\/da.22329-BIB0046|da22329-cit-0046","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0893-133X(00)00249-9","article-title":"Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline","volume":"25","author":"Rush","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/da.22329-BIB0047|da22329-cit-0047","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamainternmed.2014.1053","article-title":"Antidepressant dose, age, and the risk of deliberate self-harm","volume":"174","author":"Miller","year":"2014","journal-title":"JAMA Intern Med"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22329","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/da.22329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:03:42Z","timestamp":1671541422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22329"}},"subtitle":["Research Article: Pediatric Anxiety Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22329","relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,28]]}}}